Extracorporeal Shock Wave Therapy in Patients with Plantar Fasciitis

Phase 3

• Conditions: Plantar Fasciitis.; Plantar fascial fibromatosis

• Registration Number: IRCT2012072910439N1
• Lead Sponsor: Vice CHancellor for Research, Isfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Inclusions criteria:
- Age 18 to 65 years
- Having plantar heel pain for at least three months and point tenderness at or near the medial calcaneal insertion of the plantar fascia,
- Have no satisfactory response to common treatments such as NSAIDs and physiotherapy
- Willing to participate

Exclusion criteria:
- Having diabetes, additional foot or ankle pathology (including instability, arthritis, generalized polyarthritis, diffuse heel pad tenderness), local dermatological problems, neurological abnormalities, history of recent trauma or foot surgery, connective tissue or infectious diseases, malignancy, or vasculitis,
- Pregnant patients,
- Those who received anticoagulant therapy in the preceding six months

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Plantar Fascia Thickness. Timepoint: Before and 12 weeks after therapy. Method of measurement: Ultrasonograpgy.

Secondary Outcome Measures

Name	Time	Method
Pain. Timepoint: Before and 12 weeks after therapy. Method of measurement: Numerical rating scale.